Seeing Is Believing
SUPN is currently covered by 1 analysts with an average price target of $44.2. This is a potential upside of $13.37 (43.37%) from yesterday's end of day stock price of $30.83.
Supernus Pharmaceuticals's activity chart (see below) currently has 59 price targets and 52 ratings on display. The stock rating distribution of SUPN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 63.62% with an average time for these price targets to be met of 272.8 days.
Highest price target for SUPN is $41, Lowest price target is $41, average price target is $44.2.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 28-Feb-2024. First documented stock forecast 12-Mar-2015.
Currently out of the existing stock ratings of SUPN, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
41
$10.73 (35.45%)
43
2 months 6 days ago
14/21 (66.67%)
$9.92 (31.92%)
135
Buy
44
$13.73 (45.36%)
40
2 years 5 months 3 days ago
12/15 (80%)
$13.15 (42.63%)
241
Hold
23
4 years 18 days ago
5/7 (71.43%)
$1.85 (8.75%)
100
Buy
65
$34.73 (114.73%)
65
5 years 3 months 6 days ago
2/4 (50%)
$28.85 (79.81%)
234
Buy
57
$32.69 (134.47%)
5 years 5 months 13 days ago
1/2 (50%)
$13.06 (49.50%)
654
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?